SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Keravision(kera)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Vayda who wrote (218)8/16/1999 12:03:00 PM
From: Nine_USA  Read Replies (1) of 338
 
RE STAA (referenced in prior post)

Business Summary

STAAR Surgical Company develops, manufactures and distributes foldable intraocular lenses, and medical devices used in
connection with cataract surgery. For the three months ended 4/2/99, total revenues increased 5% to $14.8 million. Net income
decreased 60% to $673 thousand. Revenues benefitted from increased sales of the Company's refractive products particularly the
Implantable Contact Lens(TM). Earnings were offset by increased cost of sales and S/G/A expenses.

Recent Earnings Announcement

For the 3 months ended 07/02/1999, revenues were 14,774; after tax earnings were 787.
(preliminary; reported in thousands of dollars)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News